Kingscrowd

Founder Interview

Q&As with founders raising capital online. What investors want to know.

Post Archive

What Investors Want to Know: How Namecoach Turned a Mispronounced Name into $4M in ARR

Namecoach CEO Praveen Shanbhag turned a personal pain point into a SaaS business now generating $4M+ in ARR. Learn how his team is scaling across education, enterprise, and AI-powered voice tech — and why Namecoach is building a brand-new market.

Léa Bouhelier-Gautreau
Léa Bouhelier-Gautreau Apr 17, 2025
Founder Interview
What Investors Want to Know: How Namecoach Turned a Mispronounced Name into $4M in ARR

Powering the Future: Interview with Sean Luangrath, CEO of Inergy

Inergy develops compact, portable solar energy systems powering homes, businesses, and military operations. Discover how their innovative "solar in a box" technology is shaping the future of energy storage and defense applications.

Sam Fiske
Sam Fiske Apr 17, 2025
Founder Interview
Powering the Future: Interview with Sean Luangrath, CEO of Inergy

What Investors Want to Know: How Warehouse Exchange Is Becoming the Airbnb for Warehousing

Warehouse Exchange, led by serial logistics entrepreneur Jonathan Rosenthal, is building the Airbnb of warehousing. With 850 warehouses already listed and a model powered by AI, it’s poised to dominate the on-demand logistics market.

Léa Bouhelier-Gautreau
Léa Bouhelier-Gautreau Apr 15, 2025
Founder Interview
What Investors Want to Know: How Warehouse Exchange Is Becoming the Airbnb for Warehousing

What Investors Want to Know: How AptDeco Is Building the Poshmark of Furniture Resale — With Logistics Built In

AptDeco founder Reham Fagiri is making peer-to-peer furniture resale as simple as buying a sofa online. With a logistics-driven platform and new B2B partnerships, AptDeco is poised to dominate sustainable furniture resale.

Léa Bouhelier-Gautreau
Léa Bouhelier-Gautreau Apr 8, 2025
Founder Interview
What Investors Want to Know: How AptDeco Is Building the Poshmark of Furniture Resale — With Logistics Built In

Innovating Natural Medicine: Interview with Joel Stanley, Founder of AJNA BioSciences

Explore how AJNA BioSciences, led by CEO Joel Stanley, pioneers botanical drug development from prohibited plants to FDA-approved medicines for autism and depression.

Sam Fiske
Sam Fiske Mar 27, 2025
Founder Interview
Innovating Natural Medicine: Interview with Joel Stanley, Founder of AJNA BioSciences

What Investors Want to Know: How Consulta Immigration is Disrupting an Outdated Industry

Consulta Immigration, led by CEO Yasaman Soroori, is using AI to simplify and reduce the cost of immigration services, offering green cards and citizenship applications for as little as $500. With a 100% success rate and ambitious growth plans, Consulta Immigration is making immigration more accessible for individuals and businesses alike.

Léa Bouhelier-Gautreau
Léa Bouhelier-Gautreau Mar 4, 2025
Founder Interview
What Investors Want to Know: How Consulta Immigration is Disrupting an Outdated Industry

What Investors Want to Know: How Loosid is Catering to Recovery and Sober Dating

Loosid, led by CEO MJ Gottlieb, is redefining the recovery community with a focus on sober dating, accountability, and community building. With 280,000 users and growing, discover how this unique app is driving revenue and creating opportunities for members to thrive.

Sam Fiske
Sam Fiske Jan 21, 2025
Founder Interview
What Investors Want to Know: How Loosid is Catering to Recovery and Sober Dating

What Investors Want to Know: How Zirconia Is Making Infrastructure Immortal

Zirconia, led by CEO Benjamin Cook, is revolutionizing infrastructure with a ceramic surface treatment that makes concrete virtually immortal. Learn how their innovative technology is tackling global infrastructure decay, preventing corrosion, and setting new standards in concrete preservation.

Sam Fiske
Sam Fiske Jan 14, 2025
Founder Interview
What Investors Want to Know: How Zirconia Is Making Infrastructure Immortal

What Investors Want to Know: How 32 Biosciences is Transforming Microbiome Medicine

32 Biosciences, led by CEO Peter Farmakis, is tackling chronic disease by focusing on the gut microbiome. With cutting-edge diagnostics and microbiome-based interventions, this startup is poised to redefine healthcare. Discover their vision, milestones, and investment potential.

Léa Bouhelier-Gautreau
Léa Bouhelier-Gautreau Dec 13, 2024
Founder Interview
What Investors Want to Know: How 32 Biosciences is Transforming Microbiome Medicine

Take your startup investing to the next level with powerful data and expert analysis from Kingscrowd.

Become a Smarter Investor

Your Weekly Edge in the Private Markets

The Kingscrowd Newsletter gives you a weekly edge — featuring the hottest deals, exclusive data insights, industry trends, and market-moving news.

We care about the protection of your data. Read our Privacy Policy.